The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

While research has determined that there is no association between having AMD and then developing Alzheimer's or dementia, ...

A study in Alzheimer's & Dementia has demonstrated the high accuracy of plasma p-tau217 as a blood-based biomarker for ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery ...

A new study conducted by researchers from the Washington University School of Medicine identified an experimental drug that ...

The probiotic-rich drink kefir may be a potential complementary treatment for Alzheimer’s disease by helping improve ...

New research shows Alzheimer's blood tests are 90% accurate for white patients but only 73% for Black patients, raising ...

Alzheimer's blood tests show accuracy gaps across populations, raising concerns about reliable diagnosis and healthcare inequality.

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

The study is part of a growing body of research into the role of physical activity in bolstering and preserving cognition.

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...